|
Prostaglandins F
|
D011460 |
[(9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics.
] |
|
Nuclear Envelope
|
A11.284.149.165.630 |
|
|
Prostaglandins F, Synthetic
|
D011461 |
[Analogs or derivatives of prostaglandins F that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGF.
] |
|
Prostaglandins G
|
D011462 |
[A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. Most frequently encountered member of this group is the prostaglandin G2.
] |
|
Minichromosome Maintenance Complex Component 3
|
D08.811.277.040.025.159.186.300 |
|
|
Sun Protection Factor
|
D059405 |
[A measure of relative protection provided by SUNSCREENING AGENTS against burns due to ultraviolet (UV) radiation from a light source.
] |
|
Prostaglandins H
|
D011463 |
[A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. The most frequently encountered member of this group is the prostaglandin H2.
] |
|
Filing
|
L01.453.245.390 |
|
|
Epoprostenol
|
D011464 |
[A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY).
] |
|
Pinguecula
|
D059407 |
[A yellowish thickened lesion on the conjunctiva near the CORNEA representing a benign degenerative change in the CONJUNCTIVA caused by the leakage and deposition of certain blood proteins through the permeable capillaries near the LIMBUS.
] |
|
Prostaglandins, Synthetic
|
D011465 |
[Compounds obtained by chemical synthesis that are analogs or derivatives of naturally occurring prostaglandins and that have similar activity.
] |
|
Prothionamide
|
D03.383.725.394.675 |
|
|
Scorzonera
|
B01.650.940.800.575.912.250.100.775 |
|
|
F2-Isoprostanes
|
D10.251.355.411.500 |
|
|
Isoprostanes
|
D10.251.355.411 |
|
|
Sumatriptan
|
D03.633.100.473.914.907 |
|
|
Tryptamines
|
D03.633.100.473.914 |
|
|
Rectum
|
A03.556.249.249.767 |
|
|
Intestine, Large
|
A03.556.249.249 |
|
|
Lipid Metabolism, Inborn Errors
|
C18.452.584.562 |
|
